Literature DB >> 13163708

Rapidly progressive cerebral degeneration (subacute vascular encephalopathy) with mental disorder, focal disturbances, and myoclonic epilepsy.

D P JONES, S NEVIN.   

Abstract

Entities:  

Keywords:  CEREBRAL CORTEX/diseases; EPILEPSY; MENTAL DISORDERS/complications

Mesh：

Year:  1954        PMID： 13163708      PMCID： PMC503175          DOI： 10.1136/jnnp.17.2.148

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  7 in total

1.  Myoclonus epilepsy as a symptom of diffuse neuronal disease.

Authors:  C W WATSON; D DENNY-BROWN
Journal:  AMA Arch Neurol Psychiatry       Date:  1953-08

2.  Response of experimental epileptic foci to intravenous and topical metrazol.

Authors:  H C JOHNSON; A E WALKER
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1952-05

3.  [Affection manifested by diffused tetanoid contraction with variable hyperkinesia and of subacute fatal evolution].

Authors:  T ALAJOUANINE; L VAN BOGAERT
Journal:  Rev Neurol (Paris)       Date:  1950-01       Impact factor: 2.607

4.  Cerebral lipidosis: an electroencephalographic study.

Authors:  W COBB; F MARTIN; G PAMPIGLIONE
Journal:  Brain       Date:  1952-09       Impact factor: 13.501

5.  Electroencephalogram in subacute progressive encephalitis.

Authors:  W COBB; D HILL
Journal:  Brain       Date:  1950       Impact factor: 13.501

6.  [An anatomo-clinical study of the first case observed in Switzerland of a form of subacute encephalitis with cellular inclusions, with certain characteristics of leukoencephalitis sclerotisans].

Authors:  F MARTIN; J MACKEN; R HESS
Journal:  Schweiz Arch Neurol Psychiatr       Date:  1950

7.  [Clinical and electroencephalographic aspects of subacute sclerosing leukoencephalitis; differential diagnosis from other subacute encephalopathies and certain tumors in children].

Authors:  J RADERMECKER; J MACKEN
Journal:  Rev Neurol (Paris)       Date:  1951       Impact factor: 2.607
  7 in total
  30 in total

1.  SUBACUTE INCLUSION ENCEPHALITIS: A CLINICAL AND PATHOLOGICAL REVIEW.

Authors:  J A TIBBLES; W L DONOHUE; O KOFMAN; J S PRICHARD
Journal:  Can Med Assoc J       Date:  1964-02-08       Impact factor: 8.262

2.  [CONTRIBUTION TO SUBACUTE SPONGIFORM ENCEPHALOPATHY].

Authors:  M MINAUF
Journal:  Arch Psychiatr Nervenkr       Date:  1964-11-19

3.  [Clinical aspects & neuropathology of subacute presenile spongiform atrophy with dyskinetic terminal stage].

Authors:  H JACOB; W EICKE; H ORTHNER
Journal:  Dtsch Z Nervenheilkd       Date:  1958

4.  A form of subacute encephalopathy of uncertain aetiology.

Authors:  S NEVIN; W H McMENEMEY
Journal:  Proc R Soc Med       Date:  1958-07

5.  Considerations on a group of 13 patients with Creutzfeldt-Jakob disease in the region of Parma (Italy)

Authors:  G Trabattoni; A Lechi; L Bettoni; G Macchi; P Brown
Journal:  Eur J Epidemiol       Date:  1990-09       Impact factor: 8.082

6.  Temporal evolution of electroencephalographic abnormalities in Creutzfeldt-Jakob disease.

Authors:  G K Schlenska; G F Walter
Journal:  J Neurol       Date:  1989-12       Impact factor: 4.849

7.  Two neurological cases. Demonstration at the Royal College of Physicians of London.

Authors: 
Journal:  Br Med J       Date:  1979-03-17

8.  Generalized periodic discharges in the critically ill: a case-control study of 200 patients.

Authors:  Brandon Foreman; Jan Claassen; Karine Abou Khaled; Jeffrey Jirsch; Daniel M Alschuler; John Wittman; Ronald G Emerson; Lawrence J Hirsch
Journal:  Neurology       Date:  2012-10-03       Impact factor: 9.910

9.  The significance of cyclic EEG changes in Creutzfeldt-Jakob disease: prognostic value of their course in 9 patients.

Authors:  M G Terzano; D Mancia; O Zacchetti; G C Manzoni
Journal:  Ital J Neurol Sci       Date:  1981-08

10.  Electroencephalographic and clinicopathological studies on Creutzfeldt-Jakob syndrome.

Authors:  K Goto; H Umezaki; M Suetsugu
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-10       Impact factor: 10.154
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.